Senti Biosciences (SNTI) Stock Price
Senti Biosciences Price
Revenue at Senti Biosciences has contracted by 20.2% per year over the past 6 years to 22,000.00 USD. Senti Biosciences's net margin stands at -279,263.7%, down from -5,041.1% several years earlier.
Senti Biosciences stock price
Senti Biosciences business model & stock analysis
Frequently asked questions about Senti Biosciences
9 analysts currently rate the Senti Biosciences stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Senti Biosciences to generate revenue of 50,000.00 USD and earnings per share of -1.22 USD.
Converted at the current exchange rate, the Senti Biosciences share trades at 0.29 EUR (0.33 USD).
The Senti Biosciences share (SNTI) is listed on 1 stock exchanges, including: NASDAQ (SNTI).
The expected revenue of Senti Biosciences is 50,000.00 USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Senti Biosciences is -27.47 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Senti Biosciences is currently -0.27. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Senti Biosciences stock.
The price-to-sales ratio (P/S) of Senti Biosciences is currently 148.39. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Senti Biosciences stock.
The Eulerpool Quality Score for Senti Biosciences is 2/10.
The ISIN of Senti Biosciences is US81726A2096. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Senti Biosciences is SNTI. The ticker symbol is used to trade Senti Biosciences shares on the stock exchange.
Senti Biosciences stock
Senti Biosciences Peer Group
Senti Biosciences Ticker
All fundamentals and in-depth analysis of Senti Biosciences
Our stock analysis for Senti Biosciences stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Senti Biosciences. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.